Kineret (anakinra) for injection
Kineret (anakinra) – Rheumatoid Arthritis (RA) Therapy in India
Kineret (anakinra) is indicated for treating moderately to severely active Rheumatoid Arthritis (RA) in adults failing other DMARDs, and for rare autoinflammatory conditions like Cryopyrin-Associated Periodic Syndromes (CAPS), including NOMID, and Deficiency of Interleukin-1 Receptor Antagonist (DIRA), plus Still’s Disease (SJIA/AOSD) in specific age groups, working by blocking inflammation-causing interleukin-1. It’s an immunosuppressant that blocks immune chemical messengers.
| Brand Name: | Kineret |
| Generic Name: | anakinra |
| Strength: | Injection: 100 mg/0.67 mL solution in a single-use prefilled syringe for subcutaneous injection. Graduated syringe allows for doses between 20 mg and 100 mg. |
| Manufacturer: | Swedish Orphan Biovitrum AB (publ) |
| Approved By: | EMA, USFDA |
Source Details: Patient Information.
Kineret must always be used under the supervision of a Registered Medical Practitioner (RMP).
Get access to Kineret in India for treatment of Rheumatoid Arthritis (RA) on a Named Patient Import Basis.
IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to Kineret (anakinra) for injection for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).
For any queries, including information regarding imported medicine pricing estimates in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.
Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.
Contact Info
CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
EMAIL ID:
Anakinra, sold under the brand name Kineret, is a biopharmaceutical medication used to treat rheumatoid arthritis, cryopyrin-associated periodic syndromes, familial Mediterranean fever, and Still's disease. It is a slightly modified recombinant version of the human interleukin 1 receptor antagonist protein.
Is Kineret available in India?
Kineret is not widely marketed in India. It is usually accessed through a special import process under the Named Patient Program (NPP). For assistance and guidance, you can contact us by providing complete details. Like 1. How to get access in India. 2. Imported Medicine Pricing Estimates in India (Subject to Doctor’s Prescription and Regulations) 3. Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia. 4. Ensuring 100% transparency.
Get Help for Kineret Import
Need urgent access to Kineret? We’re here to help.
- Expert support for documentation & approvals
- Fast-track import coordination
- End-to-end patient assistance
Call Now | Enquire Today | WhatsApp Support Available
Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.
Email: info@indianpharmanetwork.co.in
India Pharma Network (IPN): Headquartered in New Delhi, with branch offices in Mumbai, Delhi, Gurugram, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedabad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tirupur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India. IPN facilitates access to medicines through legally compliant import pathways. Such access is arranged on a Named Patient basis and is intended strictly for personal use, in accordance with applicable regulations and subject to a valid medical prescription and necessary approvals.
NEWS/UPDATES
- Anakinra (Kineret)
- Using Machine Learning to Identify a Suitable Patient Population for Anakinra for the Treatment of COVID-19 Under the Emergency Use Authorization
Compliance & Disclaimer
India Pharma Network acts solely as a facilitator for Kineret (anakinra) access. IPN does not manufacture, sell, or promote medicines and does not provide medical advice. All imports are:
- Strictly on a Named Patient Import Basis
- Exclusively for personal use
- Not for resale, distribution, or commercial sale
- Subject to applicable Indian laws and regulatory approvals
The prescribing physician remains solely responsible for dosage, therapy, and clinical decisions.
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in